These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25427083)
1. Endocan as a potential diagnostic or prognostic biomarker for chronic kidney disease. Lee HG; Choi HY; Bae JS Kidney Int; 2014 Dec; 86(6):1079-81. PubMed ID: 25427083 [TBL] [Abstract][Full Text] [Related]
2. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. Yilmaz MI; Siriopol D; Saglam M; Kurt YG; Unal HU; Eyileten T; Gok M; Cetinkaya H; Oguz Y; Sari S; Vural A; Mititiuc I; Covic A; Kanbay M Kidney Int; 2014 Dec; 86(6):1213-20. PubMed ID: 24988065 [TBL] [Abstract][Full Text] [Related]
3. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease. Pawlak K; Mysliwiec M; Pawlak D Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664 [TBL] [Abstract][Full Text] [Related]
4. Endocan: A novel inflammatory indicator in cardiovascular disease? Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Celik T; Iyisoy A Atherosclerosis; 2015 Nov; 243(1):339-43. PubMed ID: 26448266 [TBL] [Abstract][Full Text] [Related]
5. Serum Endocan Levels are Associated With Paraoxonase 1 Concentration in Patients With Chronic Kidney Disease. Samouilidou E; Bountou E; Papandroulaki F; Papamanolis M; Papakostas D; Grapsa E Ther Apher Dial; 2018 Aug; 22(4):325-331. PubMed ID: 29368426 [TBL] [Abstract][Full Text] [Related]
6. Serum endocan and circadian heart rate variability in non-dialysis stage 5 chronic kidney disease patients. Bao Y; Wang YA; Xiao H; Wang Y; Wu Y; Yan Y; Zhu Z; Ni M; Pi CX; Liu MY; Yang JH; Li YT; Tian XK; Wang T; Zhe XW Int Urol Nephrol; 2018 Nov; 50(11):2061-2066. PubMed ID: 30276604 [TBL] [Abstract][Full Text] [Related]
7. Serum Endocan correlated with stage of chronic kidney disease and deterioration in renal transplant recipients. Su YH; Shu KH; Hu CP; Cheng CH; Wu MJ; Yu TM; Chuang YW; Huang ST; Chen CH Transplant Proc; 2014; 46(2):323-7. PubMed ID: 24655954 [TBL] [Abstract][Full Text] [Related]
8. Levels of endothelial cell-specific molecule-1 (ESM-1) in overt hypothyroidisim. Gungor A; Palabiyik SS; Bayraktutan Z; Dursun H; Gokkaya N; Bilen A; Bilen H Endocr Res; 2016 Nov; 41(4):275-280. PubMed ID: 26906498 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 and Endocan Levels. Balta Ş Angiology; 2021 Mar; 72(3):209. PubMed ID: 33086860 [No Abstract] [Full Text] [Related]
10. Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome. Kanbay A; Ceylan E; Köseoğlu Hİ; Çalışkan M; Takir M; Tulu S; Telci Çaklılı O; Köstek O; Erek A; Afsar B Clin Respir J; 2018 Jan; 12(1):84-90. PubMed ID: 27116287 [TBL] [Abstract][Full Text] [Related]
11. Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients? Ağaç MT; Kahyaoğlu B; Aksoy MMN; Cinemre FB; Vatan MB; Gündüz Y Anatol J Cardiol; 2019 Feb; 21(2):76-82. PubMed ID: 30694799 [TBL] [Abstract][Full Text] [Related]
12. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome. Bicer M; Guler A; Unal Kocabas G; Imamoglu C; Baloglu A; Bilgir O; Yuksel A; Bozkaya G; Calan M Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121 [TBL] [Abstract][Full Text] [Related]
13. The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease: A meta-analysis. Zhao T; Kecheng Y; Zhao X; Hu X; Zhu J; Wang Y; Ni J Medicine (Baltimore); 2018 Dec; 97(49):e13407. PubMed ID: 30544417 [TBL] [Abstract][Full Text] [Related]
14. Endothelial cell-specific molecule-1/endocan: Diagnostic and prognostic value in patients suffering from severe sepsis and septic shock. Pauly D; Hamed S; Behnes M; Lepiorz D; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U J Crit Care; 2016 Feb; 31(1):68-75. PubMed ID: 26489483 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of endocan and endoglin are associated with large-artery atherosclerotic stroke. He XW; Ke SF; Bao YY; Hong WJ; Shen YG; Li C; Zhu F; Wang E; Jin XP Clin Chim Acta; 2018 Mar; 478():157-161. PubMed ID: 29287901 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Cardiovascular Risk Factors, Haematological and Biochemical Parameters, and Serum Endocan Levels in Patients with Lichen Planus. Ozlu E; Karadag AS; Toprak AE; Uzuncakmak TK; Gerin F; Aksu F; Ozakpınar O; Akdeniz N Dermatology; 2016; 232(4):438-43. PubMed ID: 27508489 [TBL] [Abstract][Full Text] [Related]
17. Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus. Icli A; Cure E; Cure MC; Uslu AU; Balta S; Mikhailidis DP; Ozturk C; Arslan S; Sakız D; Sahin M; Kucuk A Angiology; 2016 Sep; 67(8):749-55. PubMed ID: 26614790 [TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-2 as a Prognostic Biomarker of Major Adverse Cardiovascular Events and All-Cause Mortality in Chronic Kidney Disease. Tsai YC; Lee CS; Chiu YW; Kuo HT; Lee SC; Hwang SJ; Kuo MC; Chen HC PLoS One; 2015; 10(8):e0135181. PubMed ID: 26274392 [TBL] [Abstract][Full Text] [Related]
19. Endocan levels in children with renal hypodysplasia. Cayci FS; Aydin Z; Aygar IS; Avci B; Inozu M; Aksoy OY; Bayrakci US Clin Nephrol; 2021 Jun; 95(6):332-337. PubMed ID: 33704056 [TBL] [Abstract][Full Text] [Related]